CORRECTION article

Front. Cardiovasc. Med., 09 June 2022

Sec. Cardiovascular Epidemiology and Prevention

Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.935850

Corrigendum: Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors

  • 1. Cardiovascular Research and Epidemiology Unit, Cardiology Department, University Hospital Vall d'Hebron and Vall d'Hebron Research Institute, Barcelona, Spain

  • 2. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain

  • 3. Recerca en Envelliment, Fragilitat i Transicions (REFiT) Barcelona Research Group, Parc Sanitari Pere Virgili and Vall d'Hebron Institute of Research, Barcelona, Spain

  • 4. Cardiology Department, Hospital Universitari de Bellvitge, Barcelona, Spain

  • 5. Bioheart, Grup de Malalties Cardiovasculars, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain

  • 6. Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain

  • 7. Statistics and Bioinformatics Unit, Vall d'Hebron Research Institute, Barcelona, Spain

  • 8. Statistics Department, Faculty of Biology, University of Barcelona, Barcelona, Spain

  • 9. Cardiology Department, University Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

  • 10. Clinical Epidemiology Unit, Hospital Universitario Cruces/BioCruces-Bizkaia Health Research Institute, Barakaldo, Spain

  • 11. Cardiology Department, Hospital German Trias i Pujol, Barcelona, Spain

  • 12. Director Plan for Cardiovascular Diseases, Pla Director de Malalties Cardiovasculars (PDMCV), Department of Health, Catalan Government, Barcelona, Spain

Article metrics

View details

1

Citations

1,3k

Views

541

Downloads

In the original article, there was a mistake in “Table 1” as published. The N for COVID-19 First wave period is 519 instead of 5,19. The corrected “Table 1” appears below.

Table 1

First wave period (24/02 to 27/04) Between waves period (28/04 to 20/09) Second wave period (21/09 to 27/12)
Pre COVID-19 COVID-19 % change P value Pre COVID-19 COVID-19 % change P value Pre COVID-19 COVID-19 % change P value
N 817 519 −36 1788 1308 −12 1308 1001 −23
Women 250 (30.60) 171 (32.95) −32 0.368 617 (34.51) 505 (32.21) −18 0.159 449 (34.33) 331 (33.07) −26 0.526
Men 567 (69.40) 348 (67.05) −39 1171 (65.49) 1063 (67.79) −9 859 (65.67) 670 (66.93) −22
Age 0.638 0.352 0.001
<80 579 (70.87) 374 (72.06) −35 1288 (72.04) 1152 (73.47) −11 883 (67.51) 738 (73.73) −16
≥80 238 (29.13) 145 (27.94) −39 500 (27.96) 416 (26.53) −17 425 (32.49) 263 (26.27) −38
Type of ACS <0.001 <0.001 <0.001
Unstable angina 143 (17.50) 84 (16.18) −41 272 (15.21) 274 (17.47) 1 167 (12.77) 167 (16.68) 0
NSTEMI 560 (68.54) 325 (62.62) −42 1249 (69.85) 997 (63.58) −20 944 (72.17) 671 (67.03) −29
STEMI 97 (11.87) 57 (10.98) −41 228 (12.75) 95 (6.06) −58 173 (13.23) 63 (6.29) −64
Other MI 8 (0.98) 43 (8.29) 438 14 (0.78) 161 (10.27) 1050 10 (0.76) 75 (7.49) 650
Other ACS 9 (1.10) 10 (1.93) 11 25 (1.4) 41 (2.61) 64 14 (1.07) 25 (2.50) 79
AMG weight, mean (SD) 32.92 (17.46) 20.44 (16.29) −38 <0.001 31.82 (16.47) 18.61 (14.44) −41 <0.001 31.19 (16.27) 17.16 (13.85) −45 <0.001
PCSA index, mean (SD) 42.11 (15.27) 42.68 (15.00) 1 0.514 42.20 (14.62) 41.24 (15.10) −2 0.064 41.79 (14.56) 42.05 (14.56) 1 0.680
Quantiles of PCSA index 0.084 0.799 0.414
1st 202 (24.72) 116 (22.35) −43 422 (23.60) 394 (25.13) −7 324 (24.77) 221 (22.08) −32
2nd 188 (23.01) 113 (21.77) −40 428 (23.94) 376 (23.98) −12 306 (23.39) 262 (26.17) −14
3rd 187 (22.89) 139 (26.78) −26 432 (24.16) 370 (23.60) −14 305 (23.32) 236 (23.58) −23
4th 215 (26.32) 145 (27.94) −33 472 (26.40) 389 (24.80) −18 335 (25.61) 249 (24.88) −26
PCI during hospitalization 353 (43.21) 242 (46.63) −31 0.220 826 (46.20) 633 (40.37) −23 0.001 619 (47.32) 420 (41.96) −32 0.010
Inhospital mortality 45 (5.51) 46 (8.86) 2 0.018 69 (3.86) 73 (4.66) 6 0.253 60 (4.59) 48 (4.80) −20 0.814
Hospital length of stay (days), mean (SD); median (p25 to p75) 9.41 (8.03);
7 (5 to 11)
7.11 (6.34);
5 (3 to 9)
−24 <0.001 8.88 (7.71);
7 (4 to 11)
8.29 (7.21);
6 (4 to 10)
−7 <0.001 9.47 (9.63);
7 (4 to 11)
8.03 (6.97);
6 (4 to 10)
−15 <0.001

Characteristics of patients admitted to hospital for acute coronary syndrome (ACS) in each period compared with the reference pre-COVID-19 period.

Numbers indicate n (%) except if otherwise stated.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

COVID-19, acute coronary syndrome, myocardial infarction, heart failure, time-series

Citation

Álvarez-Martín C, Ribera A, Marsal JR, Ariza-Solé A, Pérez-Hoyos S, Oristrell G, Soriano-Colomé T, Romaguera R, Pijoan JI, Lidón RM, Mauri J and Ferreira-González I (2022) Corrigendum: Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors. Front. Cardiovasc. Med. 9:935850. doi: 10.3389/fcvm.2022.935850

Received

04 May 2022

Accepted

17 May 2022

Published

09 June 2022

Volume

9 - 2022

Edited and reviewed by

Dexter Canoy, University of Oxford, United Kingdom

Updates

Copyright

*Correspondence: Aida Ribera

This article was submitted to Cardiovascular Epidemiology and Prevention, a section of the journal Frontiers in Cardiovascular Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics